On a disclosed annual basis, sales were KRW 2.46 trillion in 2022, the largest year in the 2022–2025 window, then fell 28.2% to KRW 1.77 trillion in 2023 and 5.5% to KRW 1.67 trillion in 2024, the smallest year, before rising 4.9% to KRW 1.75 trillion in 2025.
Operating profit fell from KRW 404.3 billion in 2022 to KRW 154.8 billion in 2023 (down 61.7%) and KRW 50.4 billion in 2024 (down 67.5%), then recovered to KRW 74.4 billion in 2025 (up 47.6%).
Operating margin moved from 16.4% in 2022 to 8.8% in 2023, 3.0% in 2024 and 4.2% in 2025, so the 2025 margin still sat well below the 2022 level.
Net profit attributable to controlling shareholders was KRW 146.2 billion in 2022, KRW 182 billion in 2023 (up 24.5%), KRW 36.4 billion in 2024 (down 80.0%) and KRW 106.1 billion in 2025 (up 191.6%). Net profit including non-controlling interests matched these figures in each year.
Press coverage described 2025 as a turnaround that broke a stretch of declining results that had run since 2022. Operating cash flow went from KRW 637.9 billion in 2022 to KRW 224.1 billion in 2023 and KRW 160 billion in 2024, then rose to KRW 300.9 billion in 2025.
Quarterly operating profit was KRW 27.6 billion in the third quarter of 2025 and KRW 19.3 billion in the fourth quarter, down 30.0% from the prior quarter, according to the disclosed figures.
Samsung Securities' review showed that fourth-quarter 2025 chlorine segment profit fell to KRW 1.5 billion from KRW 3.5 billion in the third quarter.
The first quarter of 2026 posted sales of KRW 510.7 billion and operating profit of KRW 32.7 billion, up 69.3% from the prior quarter, with reports attributing the gain to higher international chlorine-based product prices and stronger TMAC demand.
Second-quarter 2026 sales were KRW 586.3 billion and operating profit KRW 61.9 billion, up 89.5% from the prior quarter. Third-quarter 2026 sales of KRW 525.3 billion rose 18.5% year on year, while operating profit of KRW 22 billion fell 20.4% year on year.
The company attributed the sales increase to higher ammonia prices and larger TMAC shipments, and the profit decline to higher ECH raw material costs in the chlorine lineup.
Net profit attributable to controlling shareholders totaled KRW 196 billion over the last four quarters, from the fourth quarter of 2025 to the third quarter of 2026.